Cyclodextrins: their future in drug formulation and delivery.
about
α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studiesPiroxicam-β-cyclodextrin: a GI safer piroxicamPharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisAffinity-Based Drug DeliveryDrug Release from ß-Cyclodextrin Complexes and Drug Transfer into Model Membranes Studied by Affinity Capillary Electrophoresis.New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.Synthesis and self-assembly processes of monofunctionalized cucurbit[7]uril.Cyclodextrin-based pharmaceutics: past, present and future.Cyclodextrins in drug delivery: an updated reviewCyclodextrin complexes of reduced bromonoscapine in guar gum microspheres enhance colonic drug deliveryRecent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Cyclodextrins.Itraconazole--perspectives for the management of invasive aspergillosis.Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study.Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats.Safety data on 19 vehicles for use in 1 month oral rodent pre-clinical studies: administration of hydroxypropyl-ß-cyclodextrin causes renal toxicity.A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC method.Polysaccharides for colon targeted drug delivery.Nanosuspensions: a promising drug delivery strategy.Experimental and Theoretical Investigations on the Supermolecular Structure of Isoliquiritigenin and 6-O-α-D-Maltosyl-β-cyclodextrin Inclusion ComplexMolecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cellsCyclodextrins in drug delivery.Supercritical fluid technology for enhanced drug delivery.Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cellsPreclinical formulations for discovery and toxicology: physicochemical challenges.Development of imiquimod-loaded mucoadhesive films for oral dysplasia.Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Current perspectives of solubilization: potential for improved bioavailability.Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers.Mass spectrometry and molecular modeling studies on the inclusion complexes between alendronate and β-cyclodextrinSynthesis of β-cyclodextrin containing copolymer via "click" chemistry and its self-assembly in the presence of guest compounds.
P2860
Q24632720-8F0AF1AC-B311-405A-B314-BDED41906D95Q27023475-73865BBC-3102-4A03-8308-4D9B3F84ADD7Q28542435-B4BF030F-BCEE-4318-88DE-202507E95B03Q29543246-D18C1AC8-1599-4AD1-8F83-25C304BDA9BAQ30315728-BD743454-77A2-4D93-A08B-4FE4F317CD7AQ30781549-EA4D8867-10BD-49B2-945B-F21A661DBC2AQ30903645-328F0D61-13DE-463E-8534-3B534757FE40Q31060481-C7E80DF3-BD38-4676-834E-C921FC9C720DQ33393733-B14400FF-C24B-4411-A768-B51B68303CC5Q33864064-AC48B322-4678-4E8F-9D5D-CA48020120B1Q33873730-568EFBDE-33D3-46DD-9E70-C7A89C0444DEQ33876525-CFFC87DD-6D0A-4567-9D89-5F35EA62108BQ34246496-8103838D-B32E-45DF-B8A3-69F168AB6A24Q34338553-37376605-E0CC-41E3-9DC4-0814E905470FQ34552997-C1803B50-CE5D-46ED-8916-9B6D8700C70CQ34563402-F234B55E-2FD3-40B2-9C36-781C435B7A1FQ34631617-9CC53992-AEEF-4D5B-A2F9-44B16CF0C711Q34733812-9C6A6CB1-7C1A-4C0C-8842-3A2A3B18D3CAQ34761190-47FB92EF-53C8-47A2-8705-A3DD4331322CQ35105394-8B151892-348C-4F58-AE79-1C4D85E66727Q35185309-84450398-C4DE-4D27-BF23-697E70477A2EQ35196330-6EBD4CC8-1039-49F5-BA45-212155BDA33EQ35609223-FEE345A3-B6F7-4831-8DF1-B856E039C47AQ35626401-C516B3C9-1BE2-4745-8498-1C3CA8D7C3E8Q35755988-890A0C57-AEF2-4CD5-97FE-8B1A2BFB8D8BQ35806904-665289DD-266E-439D-A800-CB6B0B99E81DQ35826447-49109748-8360-4649-AC49-1F591FF3A8FCQ36088529-708F6723-703A-4503-BD3F-D99DA3150A44Q36191591-FB3CD135-C474-4D0B-8917-A3CF2839E87DQ36316735-452CB46A-8C76-4D62-AC38-FA65D26FB746Q36316895-6CB2482B-A267-4B57-B18A-4252004BD863Q36318116-F3D1B07C-6BBC-4876-B402-E995926F9939Q36609758-17154B8C-E52E-4086-9206-A3BC1C486849Q36914702-B9C33263-3EAE-487B-9086-FD20C6978D8AQ36917923-151CF338-3D45-4520-986D-CB04AB060F78Q36923086-BAE7D285-5F58-44AE-8DBF-8C88D43079B1Q37260459-8D1C7DA4-C3D1-4E2B-A4CA-2F188E291627Q37427918-9FC9B274-27A5-470D-999B-E2B6483D9E25Q37459499-D9F5CCDF-7EC5-41F2-A4C2-94C14A82BAECQ37483491-D02A4FF9-AE4D-408E-8F07-ED32B37D009A
P2860
Cyclodextrins: their future in drug formulation and delivery.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Cyclodextrins: their future in drug formulation and delivery.
@en
type
label
Cyclodextrins: their future in drug formulation and delivery.
@en
prefLabel
Cyclodextrins: their future in drug formulation and delivery.
@en
P356
P1476
Cyclodextrins: their future in drug formulation and delivery.
@en
P2093
Rajewski RA
P304
P356
10.1023/A:1012136608249
P577
1997-05-01T00:00:00Z